img

Global Human Somatotropin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Somatotropin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Human Somatotropin report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Human Somatotropin market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Growth Hormone Deficiency (GHD) and Turner Syndrome are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Human Somatotropin industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Human Somatotropin key manufacturers include Novo Nordisk, Pfizer, Eli Lilly, Merck Serono, F. Hoffmann-La Roche, Ferring Pharmaceuticals, GeneScience Pharmaceuticals, Ipsen and LG Life Sciences, etc. Novo Nordisk, Pfizer, Eli Lilly are top 3 players and held % sales share in total in 2022.
Human Somatotropin can be divided into Powder and Solvent, etc. Powder is the mainstream product in the market, accounting for % sales share globally in 2022.
Human Somatotropin is widely used in various fields, such as Growth Hormone Deficiency (GHD), Turner Syndrome, Chronic Renal Insufficiency and Prader Willi Syndrome, etc. Growth Hormone Deficiency (GHD) provides greatest supports to the Human Somatotropin industry development. In 2022, global % sales of Human Somatotropin went into Growth Hormone Deficiency (GHD) filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Somatotropin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novo Nordisk
Pfizer
Eli Lilly
Merck Serono
F. Hoffmann-La Roche
Ferring Pharmaceuticals
GeneScience Pharmaceuticals
Ipsen
LG Life Sciences
Sandoz International
Anhui Anke Biotechnology
Segment by Type
Powder
Solvent

Segment by Application


Growth Hormone Deficiency (GHD)
Turner Syndrome
Chronic Renal Insufficiency
Prader Willi Syndrome
Small for Gestational Age
SHOX Deficiency
Others

Segment by Region


North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Human Somatotropin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Human Somatotropin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Human Somatotropin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Human Somatotropin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Human Somatotropin introduction, etc. Human Somatotropin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Human Somatotropin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Human Somatotropin Market Overview
1.1 Human Somatotropin Product Overview
1.2 Human Somatotropin Market Segment by Type
1.2.1 Powder
1.2.2 Solvent
1.3 Global Human Somatotropin Market Size by Type
1.3.1 Global Human Somatotropin Market Size Overview by Type (2018-2034)
1.3.2 Global Human Somatotropin Historic Market Size Review by Type (2018-2024)
1.3.3 Global Human Somatotropin Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Human Somatotropin Sales Breakdown by Type (2018-2024)
1.4.2 Europe Human Somatotropin Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Human Somatotropin Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Human Somatotropin Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Human Somatotropin Sales Breakdown by Type (2018-2024)
2 Global Human Somatotropin Market Competition by Company
2.1 Global Top Players by Human Somatotropin Sales (2018-2024)
2.2 Global Top Players by Human Somatotropin Revenue (2018-2024)
2.3 Global Top Players by Human Somatotropin Price (2018-2024)
2.4 Global Top Manufacturers Human Somatotropin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Somatotropin Market Competitive Situation and Trends
2.5.1 Human Somatotropin Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Human Somatotropin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Somatotropin as of 2022)
2.7 Date of Key Manufacturers Enter into Human Somatotropin Market
2.8 Key Manufacturers Human Somatotropin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Human Somatotropin Status and Outlook by Region
3.1 Global Human Somatotropin Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Human Somatotropin Historic Market Size by Region
3.2.1 Global Human Somatotropin Sales in Volume by Region (2018-2024)
3.2.2 Global Human Somatotropin Sales in Value by Region (2018-2024)
3.2.3 Global Human Somatotropin Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Human Somatotropin Forecasted Market Size by Region
3.3.1 Global Human Somatotropin Sales in Volume by Region (2024-2034)
3.3.2 Global Human Somatotropin Sales in Value by Region (2024-2034)
3.3.3 Global Human Somatotropin Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Human Somatotropin by Application
4.1 Human Somatotropin Market Segment by Application
4.1.1 Growth Hormone Deficiency (GHD)
4.1.2 Turner Syndrome
4.1.3 Chronic Renal Insufficiency
4.1.4 Prader Willi Syndrome
4.1.5 Small for Gestational Age
4.1.6 SHOX Deficiency
4.1.7 Others
4.2 Global Human Somatotropin Market Size by Application
4.2.1 Global Human Somatotropin Market Size Overview by Application (2018-2034)
4.2.2 Global Human Somatotropin Historic Market Size Review by Application (2018-2024)
4.2.3 Global Human Somatotropin Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Human Somatotropin Sales Breakdown by Application (2018-2024)
4.3.2 Europe Human Somatotropin Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Human Somatotropin Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Human Somatotropin Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Human Somatotropin Sales Breakdown by Application (2018-2024)
5 North America Human Somatotropin by Country
5.1 North America Human Somatotropin Historic Market Size by Country
5.1.1 North America Human Somatotropin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Human Somatotropin Sales in Volume by Country (2018-2024)
5.1.3 North America Human Somatotropin Sales in Value by Country (2018-2024)
5.2 North America Human Somatotropin Forecasted Market Size by Country
5.2.1 North America Human Somatotropin Sales in Volume by Country (2024-2034)
5.2.2 North America Human Somatotropin Sales in Value by Country (2024-2034)
6 Europe Human Somatotropin by Country
6.1 Europe Human Somatotropin Historic Market Size by Country
6.1.1 Europe Human Somatotropin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Human Somatotropin Sales in Volume by Country (2018-2024)
6.1.3 Europe Human Somatotropin Sales in Value by Country (2018-2024)
6.2 Europe Human Somatotropin Forecasted Market Size by Country
6.2.1 Europe Human Somatotropin Sales in Volume by Country (2024-2034)
6.2.2 Europe Human Somatotropin Sales in Value by Country (2024-2034)
7 Asia-Pacific Human Somatotropin by Region
7.1 Asia-Pacific Human Somatotropin Historic Market Size by Region
7.1.1 Asia-Pacific Human Somatotropin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Human Somatotropin Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Human Somatotropin Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Human Somatotropin Forecasted Market Size by Region
7.2.1 Asia-Pacific Human Somatotropin Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Human Somatotropin Sales in Value by Region (2024-2034)
8 Latin America Human Somatotropin by Country
8.1 Latin America Human Somatotropin Historic Market Size by Country
8.1.1 Latin America Human Somatotropin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Human Somatotropin Sales in Volume by Country (2018-2024)
8.1.3 Latin America Human Somatotropin Sales in Value by Country (2018-2024)
8.2 Latin America Human Somatotropin Forecasted Market Size by Country
8.2.1 Latin America Human Somatotropin Sales in Volume by Country (2024-2034)
8.2.2 Latin America Human Somatotropin Sales in Value by Country (2024-2034)
9 Middle East and Africa Human Somatotropin by Country
9.1 Middle East and Africa Human Somatotropin Historic Market Size by Country
9.1.1 Middle East and Africa Human Somatotropin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Human Somatotropin Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Human Somatotropin Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Human Somatotropin Forecasted Market Size by Country
9.2.1 Middle East and Africa Human Somatotropin Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Human Somatotropin Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Novo Nordisk
10.1.1 Novo Nordisk Company Information
10.1.2 Novo Nordisk Introduction and Business Overview
10.1.3 Novo Nordisk Human Somatotropin Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Novo Nordisk Human Somatotropin Products Offered
10.1.5 Novo Nordisk Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Human Somatotropin Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Pfizer Human Somatotropin Products Offered
10.2.5 Pfizer Recent Development
10.3 Eli Lilly
10.3.1 Eli Lilly Company Information
10.3.2 Eli Lilly Introduction and Business Overview
10.3.3 Eli Lilly Human Somatotropin Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Eli Lilly Human Somatotropin Products Offered
10.3.5 Eli Lilly Recent Development
10.4 Merck Serono
10.4.1 Merck Serono Company Information
10.4.2 Merck Serono Introduction and Business Overview
10.4.3 Merck Serono Human Somatotropin Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Merck Serono Human Somatotropin Products Offered
10.4.5 Merck Serono Recent Development
10.5 F. Hoffmann-La Roche
10.5.1 F. Hoffmann-La Roche Company Information
10.5.2 F. Hoffmann-La Roche Introduction and Business Overview
10.5.3 F. Hoffmann-La Roche Human Somatotropin Sales, Revenue and Gross Margin (2018-2024)
10.5.4 F. Hoffmann-La Roche Human Somatotropin Products Offered
10.5.5 F. Hoffmann-La Roche Recent Development
10.6 Ferring Pharmaceuticals
10.6.1 Ferring Pharmaceuticals Company Information
10.6.2 Ferring Pharmaceuticals Introduction and Business Overview
10.6.3 Ferring Pharmaceuticals Human Somatotropin Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Ferring Pharmaceuticals Human Somatotropin Products Offered
10.6.5 Ferring Pharmaceuticals Recent Development
10.7 GeneScience Pharmaceuticals
10.7.1 GeneScience Pharmaceuticals Company Information
10.7.2 GeneScience Pharmaceuticals Introduction and Business Overview
10.7.3 GeneScience Pharmaceuticals Human Somatotropin Sales, Revenue and Gross Margin (2018-2024)
10.7.4 GeneScience Pharmaceuticals Human Somatotropin Products Offered
10.7.5 GeneScience Pharmaceuticals Recent Development
10.8 Ipsen
10.8.1 Ipsen Company Information
10.8.2 Ipsen Introduction and Business Overview
10.8.3 Ipsen Human Somatotropin Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Ipsen Human Somatotropin Products Offered
10.8.5 Ipsen Recent Development
10.9 LG Life Sciences
10.9.1 LG Life Sciences Company Information
10.9.2 LG Life Sciences Introduction and Business Overview
10.9.3 LG Life Sciences Human Somatotropin Sales, Revenue and Gross Margin (2018-2024)
10.9.4 LG Life Sciences Human Somatotropin Products Offered
10.9.5 LG Life Sciences Recent Development
10.10 Sandoz International
10.10.1 Sandoz International Company Information
10.10.2 Sandoz International Introduction and Business Overview
10.10.3 Sandoz International Human Somatotropin Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Sandoz International Human Somatotropin Products Offered
10.10.5 Sandoz International Recent Development
10.11 Anhui Anke Biotechnology
10.11.1 Anhui Anke Biotechnology Company Information
10.11.2 Anhui Anke Biotechnology Introduction and Business Overview
10.11.3 Anhui Anke Biotechnology Human Somatotropin Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Anhui Anke Biotechnology Human Somatotropin Products Offered
10.11.5 Anhui Anke Biotechnology Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Human Somatotropin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Human Somatotropin Industrial Chain Analysis
11.4 Human Somatotropin Market Dynamics
11.4.1 Human Somatotropin Industry Trends
11.4.2 Human Somatotropin Market Drivers
11.4.3 Human Somatotropin Market Challenges
11.4.4 Human Somatotropin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Human Somatotropin Distributors
12.3 Human Somatotropin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Powder
Table 2. Major Company of Solvent
Table 3. Global Human Somatotropin Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Human Somatotropin Sales by Type (2018-2024) & (MT)
Table 5. Global Human Somatotropin Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Human Somatotropin Sales by Type (2018-2024) & (US& Million)
Table 7. Global Human Somatotropin Market Share in Value by Type (2018-2024)
Table 8. Global Human Somatotropin Price by Type (2018-2024) & (USD/MT)
Table 9. Global Human Somatotropin Sales by Type (2024-2034) & (MT)
Table 10. Global Human Somatotropin Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Human Somatotropin Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Human Somatotropin Sales Market Share in Value by Type (2024-2034)
Table 13. Global Human Somatotropin Price by Type (2024-2034) & (USD/MT)
Table 14. North America Human Somatotropin Sales by Type (2018-2024) & (MT)
Table 15. North America Human Somatotropin Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Human Somatotropin Sales (MT) by Type (2018-2024)
Table 17. Europe Human Somatotropin Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Human Somatotropin Sales (MT) by Type (2018-2024)
Table 19. Asia-Pacific Human Somatotropin Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Human Somatotropin Sales (MT) by Type (2018-2024)
Table 21. Latin America Human Somatotropin Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Human Somatotropin Sales (MT) by Type (2018-2024)
Table 23. Middle East and Africa Human Somatotropin Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Human Somatotropin Sales by Company (2018-2024) & (MT)
Table 25. Global Human Somatotropin Sales Share by Company (2018-2024)
Table 26. Global Human Somatotropin Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Human Somatotropin Revenue Share by Company (2018-2024)
Table 28. Global Market Human Somatotropin Price by Company (2018-2024) & (USD/MT)
Table 29. Global Human Somatotropin Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Human Somatotropin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Somatotropin as of 2022)
Table 32. Date of Key Manufacturers Enter into Human Somatotropin Market
Table 33. Key Manufacturers Human Somatotropin Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Human Somatotropin Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Human Somatotropin Sales by Region (2018-2024) & (MT)
Table 37. Global Human Somatotropin Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Human Somatotropin Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Human Somatotropin Sales Market Share in Value by Region (2018-2024)
Table 40. Global Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 41. Global Human Somatotropin Sales by Region (2024-2034) & (MT)
Table 42. Global Human Somatotropin Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Human Somatotropin Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Human Somatotropin Sales Market Share in Value by Region (2024-2034)
Table 45. Global Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2034)
Table 46. Global Human Somatotropin Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Human Somatotropin Sales by Application (2018-2024) & (MT)
Table 48. Global Human Somatotropin Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Human Somatotropin Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Human Somatotropin Sales Market Share in Value by Application (2018-2024)
Table 51. Global Human Somatotropin Price by Application (2018-2024) & (USD/MT)
Table 52. Global Human Somatotropin Sales by Application (2024-2034) & (MT)
Table 53. Global Human Somatotropin Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Human Somatotropin Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Human Somatotropin Sales Market Share in Value by Application (2024-2034)
Table 56. Global Human Somatotropin Price by Application (2024-2034) & (USD/MT)
Table 57. North America Human Somatotropin Sales by Application (2018-2024) (MT)
Table 58. North America Human Somatotropin Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Human Somatotropin Sales by Application (2018-2024) (MT)
Table 60. Europe Human Somatotropin Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Human Somatotropin Sales by Application (2018-2024) (MT)
Table 62. Asia-Pacific Human Somatotropin Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Human Somatotropin Sales by Application (2018-2024) (MT)
Table 64. Latin America Human Somatotropin Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Human Somatotropin Sales by Application (2018-2024) (MT)
Table 66. Middle East and Africa Human Somatotropin Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Human Somatotropin Sales by Country (2018-2024) & (MT)
Table 68. North America Human Somatotropin Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Human Somatotropin Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Human Somatotropin Sales Market Share in Value by Country (2018-2024)
Table 71. North America Human Somatotropin Sales by Country (2024-2034) & (MT)
Table 72. North America Human Somatotropin Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Human Somatotropin Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Human Somatotropin Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Human Somatotropin Sales by Country (2018-2024) & (MT)
Table 76. Europe Human Somatotropin Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Human Somatotropin Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Human Somatotropin Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Human Somatotropin Sales by Country (2024-2034) & (MT)
Table 80. Europe Human Somatotropin Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Human Somatotropin Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Human Somatotropin Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Human Somatotropin Sales by Region (2018-2024) & (MT)
Table 84. Asia-Pacific Human Somatotropin Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Human Somatotropin Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Human Somatotropin Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Human Somatotropin Sales by Region (2024-2034) & (MT)
Table 88. Asia-Pacific Human Somatotropin Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Human Somatotropin Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Human Somatotropin Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Human Somatotropin Sales by Country (2018-2024) & (MT)
Table 92. Latin America Human Somatotropin Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Human Somatotropin Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Human Somatotropin Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Human Somatotropin Sales by Country (2024-2034) & (MT)
Table 96. Latin America Human Somatotropin Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Human Somatotropin Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Human Somatotropin Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Human Somatotropin Sales by Country (2018-2024) & (MT)
Table 100. Middle East and Africa Human Somatotropin Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Human Somatotropin Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Human Somatotropin Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Human Somatotropin Sales by Country (2024-2034) & (MT)
Table 104. Middle East and Africa Human Somatotropin Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Human Somatotropin Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Human Somatotropin Sales Market Share in Value by Country (2024-2034)
Table 107. Novo Nordisk Company Information
Table 108. Novo Nordisk Introduction and Business Overview
Table 109. Novo Nordisk Human Somatotropin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 110. Novo Nordisk Human Somatotropin Product
Table 111. Novo Nordisk Recent Development
Table 112. Pfizer Company Information
Table 113. Pfizer Introduction and Business Overview
Table 114. Pfizer Human Somatotropin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 115. Pfizer Human Somatotropin Product
Table 116. Pfizer Recent Development
Table 117. Eli Lilly Company Information
Table 118. Eli Lilly Introduction and Business Overview
Table 119. Eli Lilly Human Somatotropin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 120. Eli Lilly Human Somatotropin Product
Table 121. Eli Lilly Recent Development
Table 122. Merck Serono Company Information
Table 123. Merck Serono Introduction and Business Overview
Table 124. Merck Serono Human Somatotropin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 125. Merck Serono Human Somatotropin Product
Table 126. Merck Serono Recent Development
Table 127. F. Hoffmann-La Roche Company Information
Table 128. F. Hoffmann-La Roche Introduction and Business Overview
Table 129. F. Hoffmann-La Roche Human Somatotropin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 130. F. Hoffmann-La Roche Human Somatotropin Product
Table 131. F. Hoffmann-La Roche Recent Development
Table 132. Ferring Pharmaceuticals Company Information
Table 133. Ferring Pharmaceuticals Introduction and Business Overview
Table 134. Ferring Pharmaceuticals Human Somatotropin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 135. Ferring Pharmaceuticals Human Somatotropin Product
Table 136. Ferring Pharmaceuticals Recent Development
Table 137. GeneScience Pharmaceuticals Company Information
Table 138. GeneScience Pharmaceuticals Introduction and Business Overview
Table 139. GeneScience Pharmaceuticals Human Somatotropin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 140. GeneScience Pharmaceuticals Human Somatotropin Product
Table 141. GeneScience Pharmaceuticals Recent Development
Table 142. Ipsen Company Information
Table 143. Ipsen Introduction and Business Overview
Table 144. Ipsen Human Somatotropin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 145. Ipsen Human Somatotropin Product
Table 146. Ipsen Recent Development
Table 147. LG Life Sciences Company Information
Table 148. LG Life Sciences Introduction and Business Overview
Table 149. LG Life Sciences Human Somatotropin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 150. LG Life Sciences Human Somatotropin Product
Table 151. LG Life Sciences Recent Development
Table 152. Sandoz International Company Information
Table 153. Sandoz International Introduction and Business Overview
Table 154. Sandoz International Human Somatotropin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 155. Sandoz International Human Somatotropin Product
Table 156. Sandoz International Recent Development
Table 157. Anhui Anke Biotechnology Company Information
Table 158. Anhui Anke Biotechnology Introduction and Business Overview
Table 159. Anhui Anke Biotechnology Human Somatotropin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 160. Anhui Anke Biotechnology Human Somatotropin Product
Table 161. Anhui Anke Biotechnology Recent Development
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Human Somatotropin Market Trends
Table 165. Human Somatotropin Market Drivers
Table 166. Human Somatotropin Market Challenges
Table 167. Human Somatotropin Market Restraints
Table 168. Human Somatotropin Distributors List
Table 169. Human Somatotropin Downstream Customers
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Somatotropin Product Picture
Figure 2. Global Human Somatotropin Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Human Somatotropin Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Human Somatotropin Sales Status and Outlook (2018-2034) & (MT)
Figure 5. Product Picture of Powder
Figure 6. Global Powder Sales YoY Growth (2018-2034) & (MT)
Figure 7. Product Picture of Solvent
Figure 8. Global Solvent Sales YoY Growth (2018-2034) & (MT)
Figure 9. Global Human Somatotropin Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Human Somatotropin Sales Market Share by Type in 2022 & 2034
Figure 11. North America Human Somatotropin Sales Market Share in Volume by Type in 2022
Figure 12. North America Human Somatotropin Sales Market Share in Value by Type in 2022
Figure 13. Europe Human Somatotropin Sales Market Share in Volume by Type in 2022
Figure 14. Europe Human Somatotropin Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Human Somatotropin Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Human Somatotropin Sales Market Share in Value by Type in 2022
Figure 17. Latin America Human Somatotropin Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Human Somatotropin Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Human Somatotropin Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Human Somatotropin Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Somatotropin Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Somatotropin Revenue in 2022
Figure 23. Human Somatotropin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Growth Hormone Deficiency (GHD)
Figure 25. Global Growth Hormone Deficiency (GHD) Sales YoY Growth (2018-2034) & (MT)
Figure 26. Product Picture of Turner Syndrome
Figure 27. Global Turner Syndrome Sales YoY Growth (2018-2034) & (MT)
Figure 28. Product Picture of Chronic Renal Insufficiency
Figure 29. Global Chronic Renal Insufficiency Sales YoY Growth (2018-2034) & (MT)
Figure 30. Product Picture of Prader Willi Syndrome
Figure 31. Global Prader Willi Syndrome Sales YoY Growth (2018-2034) & (MT)
Figure 32. Product Picture of Small for Gestational Age
Figure 33. Global Small for Gestational Age Sales YoY Growth (2018-2034) & (MT)
Figure 34. Product Picture of SHOX Deficiency
Figure 35. Global SHOX Deficiency Sales YoY Growth (2018-2034) & (MT)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2018-2034) & (MT)
Figure 38. Global Human Somatotropin Sales by Application (2018-2034) & (US$ Million)
Figure 39. Global Human Somatotropin Sales Market Share by Application in 2022 & 2034
Figure 40. North America Human Somatotropin Sales Market Share in Volume by Application in 2022
Figure 41. North America Human Somatotropin Sales Market Share in Value by Application in 2022
Figure 42. Europe Human Somatotropin Sales Market Share in Volume by Application in 2022
Figure 43. Europe Human Somatotropin Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Human Somatotropin Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Human Somatotropin Sales Market Share in Value by Application in 2022
Figure 46. Latin America Human Somatotropin Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Human Somatotropin Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Human Somatotropin Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Human Somatotropin Manufacturing Cost Structure
Figure 51. Human Somatotropin Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed